The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Revance Therapeutics, Inc(NASDAQ:RVNC) 
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection (D...
Website: http://www.revance.com
Founded: 1999
Full Time Employees: 193
Sector: Healthcare
Industry: Biotechnology
Revance Therapeutics Days Payable Outstanding ttm (DPO)
Revance Therapeutics Days Receivable Outstanding ttm (DSO)
Revance Therapeutics Days Inventory Outstanding ttm (DIO)
Revance Therapeutics Op Cashflow Per Share ttm
Revance Therapeutics Free Cashflow Per Share ttm
Revance Therapeutics Cash Per Share ttm
Revance Therapeutics P/S ratio ttm
Revance Therapeutics (GAAP) P/E ratio ttm
Revance Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.